114 related articles for article (PubMed ID: 11356140)
1. Cytochrome P450 (CYP) mutants and substrate-specificity alterations: segment-directed mutagenesis applied to human CYP1A1.
Urban P; Jobert AS; Lainé R; Pompon D
Biochem Soc Trans; 2001 May; 29(Pt 2):128-35. PubMed ID: 11356140
[TBL] [Abstract][Full Text] [Related]
2. A combinatorial approach to substrate discrimination in the P450 CYP1A subfamily.
Taly V; Urban P; Truan G; Pompon D
Biochim Biophys Acta; 2007 Mar; 1770(3):446-57. PubMed ID: 16996693
[TBL] [Abstract][Full Text] [Related]
3. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.
Lewis BC; Mackenzie PI; Miners JO
Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138
[TBL] [Abstract][Full Text] [Related]
4. cDNA cloning and characterization of feline CYP1A1 and CYP1A2.
Tanaka N; Miyasho T; Shinkyo R; Sakaki T; Yokota H
Life Sci; 2006 Nov; 79(26):2463-73. PubMed ID: 17097115
[TBL] [Abstract][Full Text] [Related]
5. Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.
Tu Y; Deshmukh R; Sivaneri M; Szklarz GD
Drug Metab Dispos; 2008 Nov; 36(11):2371-80. PubMed ID: 18703643
[TBL] [Abstract][Full Text] [Related]
6. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
Jerabek P; Martinek V; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
[TBL] [Abstract][Full Text] [Related]
7. High-throughput enzymology and combinatorial mutagenesis for mining cytochrome P450 functions.
Urban P; Truan G; Pompon D
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):733-47. PubMed ID: 18611114
[TBL] [Abstract][Full Text] [Related]
8. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
Parikh A; Josephy PD; Guengerich FP
Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
[TBL] [Abstract][Full Text] [Related]
9. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.
Walsh AA; Szklarz GD; Scott EE
J Biol Chem; 2013 May; 288(18):12932-43. PubMed ID: 23508959
[TBL] [Abstract][Full Text] [Related]
10. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
[TBL] [Abstract][Full Text] [Related]
11. Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?
Liu N; Zhang QY; Vakharia D; Dunbar D; Kaminsky LS
Arch Biochem Biophys; 2001 May; 389(1):130-4. PubMed ID: 11370663
[TBL] [Abstract][Full Text] [Related]
12. Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues.
Lewis DF; Lake BG
Xenobiotica; 1996 Jul; 26(7):723-53. PubMed ID: 8819302
[TBL] [Abstract][Full Text] [Related]
13. Metabolic pathways of dioxin by CYP1A1: species difference between rat and human CYP1A subfamily in the metabolism of dioxins.
Shinkyo R; Sakaki T; Ohta M; Inouye K
Arch Biochem Biophys; 2003 Jan; 409(1):180-7. PubMed ID: 12464257
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Ala62Pro polymorphic variant of human cytochrome P450 1A1 using recombinant protein expression.
Lee SH; Kang S; Dong MS; Park JD; Park J; Rhee S; Ryu DY
Toxicol Appl Pharmacol; 2015 Jun; 285(3):159-69. PubMed ID: 25902338
[TBL] [Abstract][Full Text] [Related]
15. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Eugster HP; Probst M; Würgler FE; Sengstag C
Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
[TBL] [Abstract][Full Text] [Related]
16. Access channels to the buried active site control substrate specificity in CYP1A P450 enzymes.
Urban P; Truan G; Pompon D
Biochim Biophys Acta; 2015 Apr; 1850(4):696-707. PubMed ID: 25529298
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
19. Ensemble modeling of substrate binding to cytochromes P450: analysis of catalytic differences between CYP1A orthologs.
Prasad JC; Goldstone JV; Camacho CJ; Vajda S; Stegeman JJ
Biochemistry; 2007 Mar; 46(10):2640-54. PubMed ID: 17300179
[TBL] [Abstract][Full Text] [Related]
20. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
